India to Australia: Citalopram Export Trade Route

The India to Australia Citalopram corridor is one of India's established pharmaceutical export routes, with 269 shipments documented worth a combined $9.4M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 34% of all export value, reflecting the consolidated nature of India's citalopram manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $35.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with citalopram's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 18.9%, placing it at rank #18 among India's top citalopram export destinations globally.

On the import side, key buyers of Indian citalopram in Australia include NA, SANDOZ PTY LTD, , SANDOZ PTY LTD and 28 others. NA is the single largest importer with 50 shipments valued at $2.6M USD.

India's citalopram exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 105 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, IPCA LABORATORIES LIMITED, CIPLA LIMITED — together account for 86% of total trade value on this route. The average shipment value of $35.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as escitalopram sandoz (as oxalate) 10 mg t and apo-escitalopram 10mg tabletsescitalopr, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 50 shipments worth $2.6M USD — representing 27% of all citalopram imports from India on this route. A total of 31 buyers are active on this corridor.